Fighting the FDA’s Final Rule on LDTs
CEO Laurie Menser discusses the Association for Molecular Pathology’s court case against the FDA’s rule on laboratory-developed tests.
Top of the News-lir
Subscribe today for access to
Articles and Reports
Getting Started with the FDA’s New LDT Rule
Experts explain what the phase-in process will look like—and how labs can get ahead of the game.
Transitioning the Clinical Lab
What clinical laboratory professionals need to know about healthcare provision for transgender and nonbinary patients
Startup LabFinder Wants to Better Connect Patients with the Right Labs
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Quest Enters Into Management Agreement with Denver-Based Hospital System
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
LabCorp Receives Emergency FDA Approval for Molecular Zika Test
From - Laboratory Industry Report
LabCorp has received emergency approval from the U.S. Food and Drug Administration for a molecular-based rapid detection test for…
Theranos Has Invalidated Tens of Thousands of Tests
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Labs Ask OIG to Back Off on Co-Payment Collections
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Theranos Issues Thousands of Corrected or Voided Test Results
From - Laboratory Industry Report
While Theranos initially set out to change the laboratory sector with its Edison testing platform, to date it has mostly changed…
Lab Startup Focused on Consumer Subscription Model
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
PerkinElmer Continues to Make Global Transactions
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Theranos Continues With Corporate Revamp
From - Laboratory Industry Report
Theranos continues to remake itself, shedding its longtime president and expanding its board of directors…
Labs Want Congress to Intervene on LDT Regulation
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here